ORIGINAL RESEARCH
Published on 21 Mar 2024
Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma
![Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma](https://www.frontiersin.org/files/myhome article library/1366853/1366853_Thumb_400.jpg)
doi 10.3389/fphar.2024.1366853
- 779 views
- 2 citations